Overview

apolipoprotein C


'apolipoprotein C' can also refer to...

apolipoprotein C

apolipoprotein C‐I

apolipoprotein C‐II

apolipoprotein C‐III

apolipoprotein C-I

apolipoprotein C-II

Diacylglycerol oil for apolipoprotein C-II deficiency

Visualization of polymorphism in apolipoprotein C-II amyloid fibrils

Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III

C-Reactive Protein Mediates the Effect of Apolipoprotein E on Cytomegalovirus Infection

Age-Associated Accumulation of the Apolipoprotein C-III Gene T-455C Polymorphism C Allele in a Russian Population

An Association Study of −1131T>C Single Nucleotide Polymorphism of Apolipoprotein A5 Gene With Coronary Artery Disease

A Single Nucleotide Polymorphism -1131T>C in the Apolipoprotein A5 Gene Modulates the Levels of Triglyceride

C→U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC–1 from the American opossum Monodelphus domestica

The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)

Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout

Genetic linkage of hyperglycemia, body weight and serum amyloid-P in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice

Significant Impact of the +93 C/T Polymorphism in the Apolipoprotein(a) Gene on Lp(a) Concentrations in Africans But not in Caucasians: Confounding Effect of Linkage Disequilibrium

Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

A family of apolipoproteins (CI–CIV). Apo-CI (83 aa) constitutes ~10% of the protein of the VLDL (very low-density lipoprotein) and 2% of that of HDL (high-density lipoprotein) and appears to modulate the interaction of ApoE with VLDL. ApoC-II (101 aa) is a component of VLDL and is a necessary cofactor for the activation of lipoprotein lipase (EC 3.1.1.3). Mutations in the gene encoding ApoC2 cause hyperlipoproteinaemia type IB, an autosomal recessive disorder characterized by hypertriglyceridaemia, xanthomas, and susceptibility to pancreatitis and early atherosclerosis. ApoC-III (99 aa) forms 50% of the protein fraction of VLDL and inhibits lipoprotein lipase. Mutations cause deficiency of the apolipoprotein but without clinical consequences except perhaps a reduced risk of atherosclerosis. ApoC-IV (127 aa) is thought to be involved in lipoprotein metabolism.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.